IFIH1 and interstitial lung disease: Among the 333 patients with IIM-ILD, 180 (54.1%) experienced a RP pattern, of whom 110 (61.1%) were anti-MDA5 antibody-positive and 70 (38.9%) were anti-ARS antibody-positive.